Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Medical Case Reports. 2023, 11(12), 169-171
DOI: 10.12691/AJMCR-11-12-1
Case Study

Moyamoya Angiopathy Presenting with Cerebrovascular Stroke post-COVID-19 Vaccination

Mohammed Aboelnaga1, , Mahfoud El. Bashari1, Amani Alzaabi1 and Hesham Eissa1

1Zayed Military Hospital, Abu Dhabi, United Arab Emirates, Neurology Department

Pub. Date: December 06, 2023
Full Text PDF

Cite this paper

Mohammed Aboelnaga, Mahfoud El. Bashari, Amani Alzaabi and Hesham Eissa. Moyamoya Angiopathy Presenting with Cerebrovascular Stroke post-COVID-19 Vaccination. American Journal of Medical Case Reports. 2023; 11(12):169-171. doi: 10.12691/AJMCR-11-12-1

Abstract

Despite being uncommon, thrombotic complications from COVID-19 vaccinations that cause cerebrovascular events have been extensively studied. Moyamoya angiopathy (MMA) is a progressive intracranial vasculopathy that is responsible for causing recurrent strokes. This report analyzes a case of cerebrovascular stroke post-COVID-19 vaccination (inactivated-Sinovac) in a middle-aged Asian female. The patient was administered two doses of Sinovac, followed by one dose of the Pfizer vaccine, which led to the diagnosis of Moyamoya disease. The report aims to study MMA in a patient exhibiting exacerbated symptoms post-vaccination, thereby forming a basis for research regarding the safety of COVID-19 vaccinations in patients with pre-existing intracranial vasculopathy. Although such a correlation may not necessarily imply causality, caution must be exercised till future robust observations are obtained, especially considering the possibility of a shared inflammatory pathophysiological foundation between MMA and COVID-19 vaccinations.

Keywords

moya moya, vaccination, stroke, COVID-19, angiopathy

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Alammar, M.A. (2021). Ischemic stroke after AstraZeneca (COVID-19) vaccination. Saudi Med. J. [online], 42(10), pp. 1136-1139. Available from: 10.15537/smj.2021.42.10.20210326.
 
[2]  Das, S., Dubey, S., Acharya, M., Chatterjee, S., Lahiri, D., Das, G., Ray, B.K., and Kraemer, M. (2019). Thalassemia and Moyamoya syndrome: unfurling an intriguing association. J Neurol. [online], 266(11), pp. 2838-2847. Available from: https://pubmed.ncbi.nlm.nih.gov/31422456/.
 
[3]  Garg, R.K., and Paliwal, V.K. (2021). Spectrum of neurological complications following COVID-19 vaccination. Neurol. Sci. [online], 43(1), pp. 3-40.
 
[4]  Michele, M.D., Kahan, J., Berto, I., Schiavo, O.G., Iacobucci, M., Toni, D., and Merkler, A.E. (2022). Cerebrovascular complications of COVID-19 and COVID-19 vaccination. Circulation Research [online], 130, pp. 1187-1203.
 
[5]  Das S, Kanti Ray B, Pandit A, Dutta A, Bhat S, Bhattacharyya D, Prava Chakraborty A, Agrawal R, Dubey S. Covid-19 vaccine (covishield) heralding Moyamoya angiopathy. Neuroimmunology Reports. 2022; 2: 100100.